What is Bicara Therapeutics's total operating expenses?

Bicara Therapeutics (BCAX) reported total operating expenses of $60.24M in Q1 2026.

How has Bicara Therapeutics's total operating expenses changed year-over-year?

Bicara Therapeutics's total operating expenses increased by 44.2% year-over-year, from $41.79M to $60.24M.

What does total operating expenses mean?

The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.

Bicara Therapeutics BCAX Total Operating Expenses

Total Operating Expenses at other companies

ArriVent BioPharma, Inc.AVBP

$46.11M-30.9%

ImmunomeIMNM

$59.33M+24.7%

Arcus BiosciencesRCUS

$151M+0.7%

Syndax PharmaceuticalsSNDX

$99.07M-4.6%

Nuvation BioNUVB

$79.35M+27.8%

Viridian Therapeutics, Inc.VRDN

$116.31M+23.8%

Segments

By segment

See full

Reportable Segment$60.24M+44.2%

Other financials

Income statement

See full

Operating income-$60.2M-44.2%

Net income-$56.2M-52.6%

EPS (diluted)-$0.93-36.8%

Balance sheet

See full

Cash & equivalents$323.5M-30.0%

Total debt$1.4M+144%

Total equity$514.0M+12.0%

Total assets$553.6M+15.8%

Cash flow

See full

Operating cash flow-$37.5M-33.5%

CapEx$60.0K—

Free cash flow-$37.6M-33.7%

Valuation

See full

Market cap$1.64B+81.4%

Enterprise value$1.32B+288%

Returns & leverage

See full

Return on equity-32.3%—

Debt / equity0×0.0×

Current ratio13.9×-10.8×

Where this comes from

Reported directly by Bicara Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bicara Therapeutics's total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bicara Therapeutics's total operating expenses?: Bicara Therapeutics (BCAX) reported total operating expenses of $60.24M in Q1 2026.
How has Bicara Therapeutics's total operating expenses changed year-over-year?: Bicara Therapeutics's total operating expenses increased by 44.2% year-over-year, from $41.79M to $60.24M.
What does total operating expenses mean?: The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.